Preclinical cardiac perforation reduction in leadless pacing: An update to the Micra leadless pacemaker delivery system
Pacing and Clinical Electrophysiology · 2023-09 · 46 (9) · 1085-1091
DOI: 10.1111/pace.14776 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, online erschienen am 10.07.2023. Verfasst von Paul R Roberts und 5 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Southampton NHS Foundation Trust, Southampton, UK. Hauptthemen laut MEDLINE: Pacemaker, Artificial. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Leadless pacemakers have been developed to avoid some of the complications that are associated transvenous pacemakers. Pericardial effusion is a rare complication of leadless pacemaker implantation, which may result from perforation of the delivery catheter. In this study, we describe preclinical perforation performance of an updated Micra delivery catheter.
Methods
To assess preclinical perforation performance of the updated delivery catheter, three analyses were performed. First, Finite Element Analysis (FEA) computational modeling was performed to estimate the target tissue stress during Micra delivery catheter tenting. Second, benchtop perforation forces of ovine tissue were recorded for the original and updated delivery catheters. Finally, a Monte‐Carlo simulation combining human cadaveric Micra implant forces and human ventricular tissue perforation properties was performed to estimate clinical perforation performance.
Results
FEA modeling demonstrated a 66% reduction in target tissue stress when using the updated Micra delivery catheter (6.2 vs. 2.2 psi, Original vs. Updated Micra delivery catheter). Updated Micra delivery catheters required 20% more force to perforate porcine ventricular tissues in benchtop testing (μ upd = 26.9N vs. μ org = 22.4N, p = .01). Monte‐Carlo Simulation of catheter performance in human cadaveric tissues predicts 28.5% reduction of catheter‐perforated cases with the updated delivery catheter.
Conclusions
This study, using computer modelling and benchtop experimentation, has indicated that increased surface area and rounding of the updated Micra catheter tip significantly improves preclinical perforation performance. It will be important to evaluate the impact of these catheter design changes with robust registry data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Hospital Southampton NHS Foundation Trust, Southampton, UK.
- Department of Cardiovascular Sciences, UZ Leuven, Leuven, Belgium.
- Medtronic, Inc., Mounds View, Minnesota, USA.
- Electrophysiology Section, Duke University Medical Center, & Duke Clinical Research Institute, Durham, North Carolina, USA.
ORCID-Profile: Christophe Garweg, Alexander R Mattson, Jonathan P Piccini
Zitieren
APA
Roberts, P. R., Garweg, C., Yue, A. M., Mattson, A. R., Raghupathy, R., & Piccini, J. P. (2023). Preclinical cardiac perforation reduction in leadless pacing: An update to the Micra leadless pacemaker delivery system. Pacing and Clinical Electrophysiology, 46(9), 1085-1091. https://doi.org/10.1111/pace.14776
Vancouver
Roberts PR, Garweg C, Yue AM, Mattson AR, Raghupathy R, Piccini JP. Preclinical cardiac perforation reduction in leadless pacing: An update to the Micra leadless pacemaker delivery system. Pacing and Clinical Electrophysiology. 2023;46(9):1085-1091. doi:10.1111/pace.14776
BibTeX
@article{Roberts2023,
author = {Roberts, Paul R and Garweg, Christophe and Yue, Arthur M and Mattson, Alexander R and Raghupathy, Ramesh and Piccini, Jonathan P},
title = {Preclinical cardiac perforation reduction in leadless pacing: An update to the Micra leadless pacemaker delivery system},
journal = {Pacing and Clinical Electrophysiology},
year = {2023},
volume = {46},
number = {9},
pages = {1085--1091},
doi = {10.1111/pace.14776}
}
EUVIMED